Alcon Laboratories (U.K) Limited

Pentagon Park, Boundary Way, Hemel Hempstead, Hertfordshire, HP2 7UD
Telephone: +44 (0)1442 341 234
Fax: +44 (0)1442 341 200

Summary of Product Characteristics last updated on the eMC: 04/01/2012
SPC Betoptic Suspension Single Dose

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 4 - Special Precautions for Storage
Date of revision of text on the SPC:   19-Dec-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Storage conditions changed as follow:

Do not store above 25°C.

Do not freeze.

Store in the original package in order to protect from light.

Updated on 07/12/2011 and displayed until 04/01/2012
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Sep-2003
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Revision date updated in line with approval date of variation.
Updated on 14/05/2004 and displayed until 07/12/2011
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Updated on 21/08/2001 and displayed until 14/05/2004
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 06/07/2001 and displayed until 21/08/2001
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 22/06/2001 and displayed until 06/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 08/12/2000 and displayed until 22/06/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   betaxolol hydrochloride